JSC "Tatchempharmpreparaty" has a long-standing track record in innovation and drug development. Over a period of 80 years we have launched the production of more than 50 drugs and remedies. Most of them were developed by us in collaboration with research institutions and universities of Soviet Union and Russian Federation.
As a part of “Pharma-2020” national programme JSC “Tatchempharmpreparaty” together with Kazan Federal University will launch a state-of-the-art drug development center and a brand new experimental pilot plant in 2012-2013. The total cost of the joint project is estimated at $30m and is sponsored by the Federal Government.
The "Pharma-2020" programme is aimed at import substitution of foreign medicines. The overall Federal expenditures for "Pharma-2020" are planned to reach $6.2bn for the period until 2020. As a result Federal Government expects to increase domestic products share in the internal market consumption by up to 50 % (in value terms) by 2020.